JUVMO
NDC 0074-5925, Tavapadon, tablet, from AbbVie Inc..
- Product NDC
- 0074-5925
- Status
- Listed
- Labeler
- AbbVie Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220415
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0074-5925 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAVAPADON.25 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0074-5925-21 | 00074592521 | 21 TABLET in 1 BOTTLE (0074-5925-21) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/1ae6df6e-6ca0-420f-bec9-effa7acdd085
Use it
Look up 0074-5925 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0074-5925 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0074-5925. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.